These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 19300224)

  • 1. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
    Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
    Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical review of melanoma pathology reports for patients referred to the Western Australian Melanoma Advisory Service.
    Monshizadeh L; Hanikeri M; Beer TW; Heenan PJ
    Pathology; 2012 Aug; 44(5):441-7. PubMed ID: 22772338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
    Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of AJCC staging parameters in primary cutaneous melanoma: an analysis of 4,924 cases.
    Niebling MG; Haydu LE; Karim RZ; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2013 Nov; 20(12):3969-75. PubMed ID: 23851608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma.
    Busam KJ
    Am J Clin Pathol; 2001 May; 115(5):743-6. PubMed ID: 11345839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of thorough block sampling in the histologic evaluation of melanomas.
    Dyson SW; Bass J; Pomeranz J; Jaworsky C; Sigel J; Somach S
    Arch Dermatol; 2005 Jun; 141(6):734-6. PubMed ID: 15967919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The advantage of using a synoptic pathology report format for cutaneous melanoma.
    Karim RZ; van den Berg KS; Colman MH; McCarthy SW; Thompson JF; Scolyer RA
    Histopathology; 2008 Jan; 52(2):130-8. PubMed ID: 18184262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
    Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma.
    Colloby PS; West KP; Fletcher A
    J Pathol; 1991 Mar; 163(3):245-50. PubMed ID: 2013827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement.
    Busam KJ; Antonescu CR; Marghoob AA; Nehal KS; Sachs DL; Shia J; Berwick M
    Am J Clin Pathol; 2001 Jun; 115(6):856-60. PubMed ID: 11392882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
    Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
    Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microsatellites as a prognostic factor in primary malignant melanoma.
    Shaikh L; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR; Kashani-Sabet M
    Arch Dermatol; 2005 Jun; 141(6):739-42. PubMed ID: 15967920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic study of recurrent Clark level II melanomas.
    Glass LF; Guffey JM; Schroer KR; Reintgen D
    Semin Surg Oncol; 1993; 9(3):202-7. PubMed ID: 8516604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance of histopathologic parameters in cutaneous melanoma: Clinical implications.
    Patrawala S; Maley A; Greskovich C; Stuart L; Parker D; Swerlick R; Stoff B
    J Am Acad Dermatol; 2016 Jan; 74(1):75-80. PubMed ID: 26514601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of histopathological reporting on melanoma and influence of use of a synoptic template.
    Haydu LE; Holt PE; Karim RZ; Madronio CM; Thompson JF; Armstrong BK; Scolyer RA
    Histopathology; 2010 May; 56(6):768-74. PubMed ID: 20546342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, staging (new system), and prognosis of cutaneous melanoma.
    Cho YR; Chiang MP
    Clin Plast Surg; 2010 Jan; 37(1):47-53. PubMed ID: 19914457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
    Niakosari F; Kahn HJ; Marks A; From L
    Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.